Campaña Maria B, Perkins Madison R, McCabe Maxwell C, Neumann Andrew, Larson Eric D, Fantauzzo Katherine A
Department of Craniofacial Biology, School of Dental Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Department of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Nat Commun. 2025 May 22;16(1):4754. doi: 10.1038/s41467-025-59938-1.
The platelet-derived growth factor receptor (PDGFR) family of receptor tyrosine kinases consists of two receptors, PDGFRα and PDGFRβ, that homodimerize and heterodimerize upon ligand binding. Here, we tested the hypothesis that differential internalization and trafficking dynamics of the various PDGFR dimers underlie differences in downstream intracellular signaling and cellular behavior. Using a bimolecular fluorescence complementation approach, we demonstrated that PDGFRα/β heterodimers are rapidly internalized into early endosomes. We showed that PDGFRα/β heterodimer activation does not induce downstream phosphorylation of ERK1/2 and significantly inhibits cell proliferation. Further, we identified MYO1D as a protein that preferentially binds PDGFRα/β heterodimers and demonstrated that knockdown of MYO1D leads to retention of PDGFRα/β heterodimers at the plasma membrane, increased phosphorylation of ERK1/2 and increased cell proliferation. Collectively, our findings impart valuable insight into the molecular mechanisms by which specificity is introduced downstream of PDGFR activation to differentially propagate signaling and generate distinct cellular responses.
血小板衍生生长因子受体(PDGFR)家族的受体酪氨酸激酶由两种受体组成,即PDGFRα和PDGFRβ,它们在配体结合后会形成同二聚体和异二聚体。在此,我们验证了这样一种假说,即各种PDGFR二聚体的内化和运输动力学差异是下游细胞内信号传导和细胞行为差异的基础。使用双分子荧光互补方法,我们证明了PDGFRα/β异二聚体迅速内化到早期内体中。我们发现,PDGFRα/β异二聚体的激活不会诱导ERK1/2的下游磷酸化,并且会显著抑制细胞增殖。此外,我们鉴定出MYO1D是一种优先结合PDGFRα/β异二聚体的蛋白质,并证明敲低MYO1D会导致PDGFRα/β异二聚体滞留在质膜上,增加ERK1/2的磷酸化并增加细胞增殖。总的来说,我们的研究结果为PDGFR激活下游引入特异性以差异传播信号并产生不同细胞反应的分子机制提供了有价值的见解。